A Study Investigating the Distribution and Metabolism of Three 14C-labeled Radioactive Study Compounds

NCT04676906 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers
Type 2 Diabetes

Interventions

DRUG: NNC0113-6861
DRUG: NNC0113-6860
DRUG: NNC0113-6891

Sponsor

Novo Nordisk A/S